Arrowhead Pharmaceuticals, Inc. (ARWR)
70.24
+2.26
(+3.32%)
USD |
NASDAQ |
Apr 17, 10:39
Arrowhead Pharmaceuticals Shareholders Equity (Quarterly) : 568.42M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.141B |
| Johnson & Johnson | -- |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Catalyst Pharmaceuticals, Inc. | 954.27M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.604B |
| Total Liabilities (Quarterly) | 1.041B |
| Debt to Equity Ratio | 1.21 |
| Current Ratio | 3.380 |
| Net Debt Paydown Yield | 0.36% |